Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05928936 · ClinicalTrials.gov registry record · Phase 2

Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

A Phase 2 study of Chronic Kidney Disease, sponsored by Emory University.

Recruiting
Registry status
Phase 2
Development phase
156
Enrollment target
2
Study locations

NCT05928936 is a Phase 2 study of Chronic Kidney Disease that is actively recruiting participants, run by Emory University. The registered enrollment target is 156 participants, below the 3,205-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05928936, a Phase 2 study of Chronic Kidney Disease, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
Phase 2
Development phase
156 participants
Enrollment target
2
Study locations

Study Summary

The goals of this project are to investigate the mechanisms and potential therapies related to exercise capacity in persons with chronic kidney disease (CKD).

Conditions Studied

Chronic Kidney Disease

Interventions

  • DRUG Placebo
  • DRUG Sodium Bicarbonate
  • BEHAVIORAL Exercise Training

Study Locations (2)

Georgia

  • Emory Clinic - Atlanta
  • Atlanta VA Medical Center - Decatur

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2022-11-11
Est. Completion 2028-06-01
Phase Phase 2

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05928936

The ClinicalTrials.gov registry entry for NCT05928936 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,205-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (95% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT05928936 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05928936 about?

NCT05928936 is a clinical study titled "Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD". The goals of this project are to investigate the mechanisms and potential therapies related to exercise capacity in persons with chronic kidney disease (CKD).

What is the current status of trial NCT05928936?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 156 participants. The study started on 2022-11-11. Estimated completion is 2028-06-01.

What conditions does trial NCT05928936 study?

This clinical trial studies the following conditions: Chronic Kidney Disease.

What interventions are being tested in trial NCT05928936?

The interventions under investigation include: Placebo (DRUG), Sodium Bicarbonate (DRUG), Exercise Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05928936?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05928936 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Kidney Disease

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.